COSM Latest Press Releases

-- June 18, 2026 --

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity Globe Newswire 3:34 PM

-- June 17, 2026 --

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States Globe Newswire 3:35 PM

Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products Globe Newswire 9:27 AM

-- June 15, 2026 --

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit Globe Newswire 9:00 AM

-- June 12, 2026 --

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines Globe Newswire 3:33 PM

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit Globe Newswire 9:29 AM

-- June 11, 2026 --

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio Globe Newswire 3:31 PM

Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance Globe Newswire 9:35 AM

-- June 10, 2026 --

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries Globe Newswire 3:32 PM

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform - Record Growth with U.S. Expansion Underway Globe Newswire 9:00 AM

-- June 9, 2026 --

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN Globe Newswire 3:30 PM

-- June 8, 2026 --

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives Globe Newswire 10:00 AM

-- June 5, 2026 --

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories Globe Newswire 9:25 AM

-- June 4, 2026 --

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz Globe Newswire 3:57 PM

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value Globe Newswire 9:25 AM

-- June 2, 2026 --

Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to EUR 25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline Globe Newswire 8:00 AM

-- June 1, 2026 --

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657 Globe Newswire 8:25 AM

-- May 26, 2026 --

Cosmos Health Releases 2026-2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 - Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation Globe Newswire 9:34 AM

-- May 21, 2026 --

Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants ACCESS Newswire 2:20 PM

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway ACCESS Newswire 9:15 AM

-- May 14, 2026 --

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its EUR 50M R&D Program; EIB Financing Represents up to 50%, or EUR 25M, under the EIB's Venture Debt Program ACCESS Newswire 9:00 AM

-- May 12, 2026 --

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 ACCESS Newswire 10:15 AM

-- May 11, 2026 --

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months ACCESS Newswire 2:25 PM

-- May 8, 2026 --

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed ACCESS Newswire 11:25 AM

-- May 6, 2026 --

Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness ACCESS Newswire 10:35 AM

-- April 30, 2026 --

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months ACCESS Newswire 12:50 PM

-- April 21, 2026 --

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products ACCESS Newswire 12:51 PM

-- April 20, 2026 --

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio ACCESS Newswire 10:55 AM

-- April 17, 2026 --

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39 Higher Bioavailability and Designed to Support Joint Health ACCESS Newswire 2:00 PM

-- April 16, 2026 --

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30% ACCESS Newswire 3:15 PM

-- April 15, 2026 --

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments ACCESS Newswire 9:25 AM

-- April 13, 2026 --

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units ACCESS Newswire 12:50 PM

-- April 10, 2026 --

Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months ACCESS Newswire 9:40 AM

-- April 8, 2026 --

Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction ACCESS Newswire 11:10 AM

-- April 1, 2026 --

Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets ACCESS Newswire 11:42 AM

-- March 11, 2026 --

Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000 Globe Newswire 1:45 PM

-- March 10, 2026 --

Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000 Globe Newswire 9:00 AM

-- February 24, 2026 --

Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board Globe Newswire 12:30 PM

-- February 19, 2026 --

Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value Globe Newswire 11:30 AM

-- February 18, 2026 --

Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK's Second-Largest Beauty and Health Retailer Globe Newswire 1:45 PM

Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer Globe Newswire 10:17 AM

-- February 17, 2026 --

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026 Globe Newswire 11:25 AM

-- February 11, 2026 --

Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies Globe Newswire 12:10 PM

-- January 20, 2026 --

Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue Globe Newswire 10:45 AM